SCHEMBL6436014

SCHEMBL6436014

CC1(C)Cc2ccoc2C(=O)N1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.45
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
GFER P55789 1/20 0.43
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
NCOA1 Q15788 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
BUB1 O43683 1/20 0.35
ALOX15 P16050 1/20 0.35
CDC7 O00311 2/20 0.33
TSHR P16473 1/20 0.33
MAPT P10636 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22606096 0.70 ALDH1A1 (0.38) HTTHPGDHSD17B10KDM4EALDH1A1
SCHEMBL4842012 0.67 NPSR1 (0.62) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL6434544 0.63 ALDH1A1 (0.32) ALDH1A1MAPT
SCHEMBL21768055 0.62 HTT (0.58) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL22782798 0.62 HTT (0.58) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL20721220 0.62 NQO1 (0.30)
SCHEMBL4923925 0.62 HTT (0.54) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL4845197 0.60 HPGD (1.00) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL21768027 0.60 HTT (0.55) HTTHPGDHSD17B10GFERKDM4E
SCHEMBL7505165 0.60 HPGD (0.60) HTTHPGDHSD17B10GFERKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1288203-B1 Cyclic nitrones and pharmaceutical compositions containing them AVENTIS PHARMA INC (US) 2005-04-20 EP disclosed
EP-1288203-A1 Cyclic nitrones and pharmaceutical compositions containing them Aventis Pharmaceuticals Inc. (US) 2003-03-05 EP disclosed
US-5962469-A PREVENTION OF OXIDATION TISSUE DAMAGE BY FREE RADICALS HOECHST MARION ROUSSEL INC. (US) 1999-10-05 US disclosed
EP-0863878-A1 CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST MARION ROUSSEL, INC. (US) 1998-09-16 EP disclosed
WO-1997010218-A1 CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST MARION ROUSSEL, INC. (US) 1997-03-20 WO disclosed